Gubbins Paul O, McConnell Scott A, Gurley Bill J, Fincher Timothy K, Franks Amy M, Williams David K, Penzak Scott R, Saccente Michael
Department of Pharmacy Practice, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock 72205-7122, USA.
Pharmacotherapy. 2004 Apr;24(4):460-7. doi: 10.1592/phco.24.5.460.33350.
To evaluate the effect of repeated ingestion of grapefruit juice on the systemic availability of itraconazole (ITZ) and hydroxyitraconazole (OHITZ) serum concentrations in subjects administered hydroxypropyl-beta-cyclodextrin-ITZ (HP-beta-CD ITZ) oral solution.
Randomized, two-period, crossover study.
College of pharmacy research unit.
Twenty healthy, adult volunteers (10 men, 10 women).
Subjects received 240 ml of regular-strength grapefruit juice from frozen concentrate or bottled purified water 3 times/day for 2 days. On the third day they received a single dose of HP-beta-CD ITZ oral solution 200 mg (20 ml) with 240 ml of the beverage. Two hours after dosing they received another 240 ml of the beverage.
Repeated blood samples were drawn for 72 hours after dosing. After a 14-day washout period, subjects were crossed over to the beverage they had not received previously and the above procedure was repeated. There was no difference in peak ITZ concentration (Cmax) or time to Cmax (Tmax). Coadministration of grapefruit juice reduced OHITZ Cmax nearly 10%, but this difference was not statistically significant. It produced a statistically significant increase in ITZ area under the concentration-time curves from 0-48 hours (AUC(0-48)) (17%) and from time zero extrapolated to infinity (AUC(0-infinity)) (19.5%). Apparent oral clearance of ITZ was significantly reduced (14%). Significant changes in OHITZ exposure were not observed; however, grapefruit juice coadministration produced statistically significant decreased mean OHITZ:ITZ AUC(0-48) and AUC(0-infinity) ratios. Grapefruit juice also decreased the mean OHITZ:ITZ Cmax ratio, but the difference was not statistically significant.
Repeated grapefruit juice consumption moderately affects ITZ systemic availability in subjects administered HP-beta-CD ITZ oral solution. Unlike previous findings with ITZ capsules, changes in the disposition of ITZ and OHITZ after repeated grapefruit juice consumption are consistent with grapefruit juice inhibition of intestinal cytochrome P450 3A4.
评估多次摄入葡萄柚汁对服用羟丙基-β-环糊精-伊曲康唑(HP-β-CD ITZ)口服溶液的受试者体内伊曲康唑(ITZ)的全身可用性及羟基伊曲康唑(OHITZ)血清浓度的影响。
随机、两周期、交叉研究。
药学院研究单位。
20名健康成年志愿者(10名男性,10名女性)。
受试者每天3次,每次服用240 ml由冷冻浓缩液制成的常规浓度葡萄柚汁或瓶装纯净水,共服用2天。在第3天,他们服用一剂200 mg(20 ml)的HP-β-CD ITZ口服溶液,并同时饮用240 ml上述饮料。给药后2小时,他们再饮用240 ml该饮料。
给药后72小时内多次采集血样。经过14天的洗脱期后,受试者交叉服用他们之前未服用过的饮料,并重复上述程序。ITZ的峰浓度(Cmax)或达峰时间(Tmax)没有差异。葡萄柚汁与HP-β-CD ITZ同时服用使OHITZ的Cmax降低了近10%,但这一差异无统计学意义。它使ITZ在0至48小时的浓度-时间曲线下面积(AUC(0 - 48))有统计学意义地增加了17%,从零时间外推至无穷大的AUC(AUC(0 - ∞))增加了19.5%。ITZ的表观口服清除率显著降低(14%)。未观察到OHITZ暴露有显著变化;然而,葡萄柚汁与HP-β-CD ITZ同时服用使OHITZ:ITZ的AUC(0 - 48)和AUC(0 - ∞)比值有统计学意义地降低。葡萄柚汁还降低了OHITZ:ITZ的Cmax均值比值,但差异无统计学意义。
多次饮用葡萄柚汁对服用HP-β-CD ITZ口服溶液的受试者体内ITZ的全身可用性有适度影响。与之前关于ITZ胶囊的研究结果不同,多次饮用葡萄柚汁后ITZ和OHITZ处置的变化与葡萄柚汁对肠道细胞色素P450 3A4的抑制作用一致。